Advertisement

Advertisement
Orthopaedics
Researchers gain new insight into cancer metastasis Print E-mail
User Rating: / 0
Tuesday, 06 January 2009
Medical Research News Few things are as tiresome as house hunting and moving. Unfortunately, metastatic cancer cells have the relocation process down pat. Tripping nimbly from one abode to another, these migrating cancer cells frequently prove far more deadly than the original tumor.
Read more...
 
Oral bisphosphonates linked to increased jaw necrosis Print E-mail
User Rating: / 0
Friday, 02 January 2009
Medical Research News Researchers at the University Of Southern California, School Of Dentistry release results of clinical data that links oral bisphosphonates to increased jaw necrosis.
Read more...
 
FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas Print E-mail
User Rating: / 0
Saturday, 20 December 2008
Pharmaceutical News The U.S. Food and Drug Administration has agreed Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
Read more...
 
New bone and tissue regeneration technique Print E-mail
User Rating: / 0
Tuesday, 16 December 2008
Medical Research News Using stem cell lines not commonly combined, researchers at Columbia University Medical Center have designed a new way to "grow" bone and other tissues.
Read more...
 
Three-quarters of youths with type 1 diabetes have vitamin D deficiency Print E-mail
User Rating: / 0
Tuesday, 16 December 2008
Child Health News Three-quarters of youths with type 1 diabetes were found to have insufficient levels of vitamin D, according to a study by researchers at the Joslin Diabetes Center - findings that suggest children with the disease may need vitamin D supplementation to prevent bone fragility later...
Read more...
 
Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane Print E-mail
User Rating: / 0
Monday, 15 December 2008
Drug Trials An interim study of a breast cancer prevention study using exemestane (Aromasin) finds an "acceptable" level of bone loss.
Read more...
 
Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size Print E-mail
User Rating: / 0
Monday, 15 December 2008
Drug Trials New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.
Read more...
 
Scientists create first functional stem-cell niche model Print E-mail
User Rating: / 0
Thursday, 11 December 2008
Medical Research News Like it or not, your living room possibly says a lot about you. Given a few uninterrupted moments to poke around, a stranger could possibly get a beautiful fine concept of your likes and dislikes, and possibly even your future plans.
Read more...
 
Thiazolidinediones doubles risk of fractures in women Print E-mail
User Rating: / 0
Thursday, 11 December 2008
Women's Health News New findings out of Wake Forest University School of Medicine and the University of East Anglia show that long-term use of a popular class of oral diabetic drugs doubles the risk of fractures in women with type 2 diabetes.
Read more...
 
Dacogen data presented on trial in seniors with acute myeloid leukemia Print E-mail
User Rating: / 0
Thursday, 11 December 2008
Drug Trials Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most usual form of leukemia.
Read more...
 
Drug combo improves or stabilizes disease for relapsed multiple myeloma patients Print E-mail
User Rating: / 0
Thursday, 11 December 2008
Medical Research News Mayo Clinic researchers have found that a new combination of medications designed to maximize immune functions advanced or stabilized multiple myeloma for 76 percent of patients who had relapsed after preceding treatment.
Read more...
 
Kiadis Pharma receives two orphan drug designations for Reviroc Print E-mail
User Rating: / 0
Tuesday, 09 December 2008
Pharmaceutical News Kiadis Pharma has announced that the U.S. Food and Drug Administration (FDA) has granted its product Reviroc Orphan Drug Designations (ODD) for the treatment of 2 types of Non-Hodgkin Lymphoma (NHL).
Read more...
 
Hematopoietic stem cells found to reproduce more slowly than expected Print E-mail
User Rating: / 0
Monday, 08 December 2008
Medical Research News Investigators from Massachusetts General Hospital (MGH) have found a subpopulation of hematopoietic stem cells, the source of all blood and immune system cells, that reproduce much more slowly than previously anticipated.
Read more...
 
Stem cells derived from bone marrow may offer novel therapeutic option for epidermolysis bullosa Print E-mail
User Rating: / 0
Friday, 05 December 2008
Medical Research News Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in Blood, the official journal of the American...
Read more...
 
New set of controls for stem cells discovered Print E-mail
User Rating: / 0
Thursday, 04 December 2008
Medical Research News Natural changes in voltage that happen across the membrane of adult human stem cells are a powerful controlling issue in the process by which these stem cells differentiate, according to research published by Tufts University scientists.
Read more...
 
Spinal stapling - new treatment alternative for scoliosis Print E-mail
User Rating: / 0
Thursday, 04 December 2008
Medical Procedure News Morgan Stanley Children's Hospital of NewYork-Presbyterian is one of only a few hospitals in the country to offer spinal stapling, a new treatment alternative for young people with scoliosis, an abnormal curvature of the spine that is painful and can restrict breathing.
Read more...
 
Virtual colonoscopy has potential to screen for colorectal cancer and osteoporosis at same time Print E-mail
User Rating: / 0
Wednesday, 03 December 2008
Devices/Technology New research reveals that computed tomography (CT) colonography, also known as virtual colonoscopy, has the potential to screen for 2 diseases at once-colorectal cancer and osteoporosis, both of which regularly affect adults over age 50.
Read more...
 
Smart materials to revolutionise surgical implants Print E-mail
User Rating: / 0
Tuesday, 02 December 2008
Devices/Technology A brand new process that could revolutionise the reliability and durability of surgical implants, like hip and knee replacements, has today, 2 December 08, received recognition for its medical and commercial potential by achieving one of the world's most sought after accolades.
Read more...
 
New stapling treatment may help reverse scoliosis Print E-mail
User Rating: / 0
Tuesday, 02 December 2008
Medical Procedure News Morgan Stanley Children's Hospital of NewYork-Presbyterian is one of only a few hospitals in the country to offer spinal stapling, a new treatment alternative for young people with scoliosis, an abnormal curvature of the spine that is painful and can restrict breathing.
Read more...
 
Fruit flies provide new insights into a brain-damaging disease mucolipidosis type IV Print E-mail
User Rating: / 0
Friday, 28 November 2008
Medical Research News Johns Hopkins researchers have used fruit flies to gain new insights into a brain-damaging disorder afflicting children.Their work suggests a possible therapy for the disease, for which there is presently no treatment.
Read more...
 
Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers Print E-mail
User Rating: / 0
Wednesday, 26 November 2008
Medical Research News Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the broadly used anti-inflammatory medications increase...
Read more...
 
Nplate receives positive opinion for marketing authorisation in Europe Print E-mail
User Rating: / 0
Sunday, 23 November 2008
Pharmaceutical News Amgen has announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive impression recommending marketing authorisation for Nplate (romiplostim) in the European Union (EU).
Read more...
 
Neurological health risk in children with blunt head injuries: fashion hair beads Print E-mail
User Rating: / 0
Sunday, 23 November 2008
Child Health News An intriguing article published in the December 2008 online issue of Journal of Neurosurgery: Pediatrics may come as quite a surprise to parents, particularly those with small girls.
Read more...
 
FDA approves GSK's Promacta (Eltrombopag) Print E-mail
User Rating: / 0
Saturday, 22 November 2008
Pharmaceutical News GlaxoSmithKline has announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an...
Read more...
 
Computed tomography technology shows anorexia impairs adolescent bone development Print E-mail
User Rating: / 0
Tuesday, 18 November 2008
Devices/Technology Children and teenagers with even mild cases of anorexia exhibit abnormal bone structure, according to a new study appearing in the December issue of Radiology and presented at the yearly meeting of the Radiological Society of North America (RSNA).
Read more...
 
Discovery of new mechanism that regulates formation of blood vessels Print E-mail
User Rating: / 0
Tuesday, 18 November 2008
Medical Research News Researchers in one of the external groups of the Instituto Gulbenkian de Ciencia (IGC), in Portugal, have discovered a novel mechanism which regulates the process whereby new blood vessels are formed and wounds cure, including chronic wounds, like those found in diabetic...
Read more...
 
Proton therapy may reduce serious side effect of lung cancer treatment Print E-mail
User Rating: / 0
Monday, 17 November 2008
Medical Procedure News Patients with locally enhanced lung cancer who receive chemotherapy and proton therapy, a specialized form a radiation therapy only available in a few centers in the United States, have fewer instances of a serious side effect called bone marrow toxicity than patients who...
Read more...
 
Osteoporosis drugs may prevent future bone growth Print E-mail
User Rating: / 0
Friday, 14 November 2008
Pharmaceutical News Patients who start and eventually stop regimens of a general class of osteoporosis drugs called bisphosphonates may be unable to benefit from parathyroid hormone (PTH), which can rebuild bone mass lost because of enhanced stage osteoporosis.
Read more...
 
Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord Print E-mail
User Rating: / 0
Thursday, 13 November 2008
Medical Research News Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord.
Read more...
 
New approach to bone marrow transplantation found to be a safe and effective cure for sickle cell di Print E-mail
User Rating: / 0
Saturday, 08 November 2008
Medical Procedure News A unique approach to bone marrow transplantation pioneered in part by a Children's Hospital of Pittsburgh of UPMC physician has proven to be the only safe and effective cure for sickle cell disease, according to a new study.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>

Results 1 - 30 of 171
Latest news in this category:

Researchers gain new insight into cancer metastasis
Tuesday, 06 January 2009
Medical Research News Few things are as tiresome as house hunting and moving. Unfortunately, metastatic cancer cells have the relocation process down pat. Tripping nimbly from one abode to another, these migrating cancer cells frequently prove far more deadly than the original tumor.

Oral bisphosphonates linked to increased jaw necrosis
Friday, 02 January 2009
Medical Research News Researchers at the University Of Southern California, School Of Dentistry release results of clinical data that links oral bisphosphonates to increased jaw necrosis.

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas
Saturday, 20 December 2008
Pharmaceutical News The U.S. Food and Drug Administration has agreed Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.

New bone and tissue regeneration technique
Tuesday, 16 December 2008
Medical Research News Using stem cell lines not commonly combined, researchers at Columbia University Medical Center have designed a new way to "grow" bone and other tissues.

Three-quarters of youths with type 1 diabetes have vitamin D deficiency
Tuesday, 16 December 2008
Child Health News Three-quarters of youths with type 1 diabetes were found to have insufficient levels of vitamin D, according to a study by researchers at the Joslin Diabetes Center - findings that suggest children with the disease may need vitamin D supplementation to prevent bone fragility later...

Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
Monday, 15 December 2008
Drug Trials An interim study of a breast